Personalized Medicine - Standardisation
development of personalised medicine
Personalized Medicine Molecular
pan-European pre-analytical CEN
pre-analytical workflow steps
generic Pre-analytical procedures
important pre-analytical workflows
vitro DIAgnostics
International Standards
insufficient quality assurance of diagnostic practice
biomedical research
large European public research consortia
official European Standards Organisation
international standardisation
SPIDIA4P
resulting quality of samples
Corresponding External Quality Assurance
new standards developments
sample collection
public institutions
great progress
insufficient guidelines
diagnostic test results unreliable
strong consortium
post collection changes
validation studies data
compromised patients’ samples
extra-cellular biomolecules’ profiles
access
Technical Specifications
preservation
patient stratification
improvements of diagnosis
evidence
ISO
training
counselling
education
storage
EQA
private industry
experienced partners
coordination
additional major foci
support action
prognosis of disease outcome
stakeholder organisations involvements
transport
SMEs
biomarker discovery
Schemes
comprehensive portfolio
crucial moment
project
processing
impacts of
biobanks
SPIDA4P